Discussion in 'General ME/CFS News' started by strategist, Dec 29, 2017.
Michael Sharpe tried to argue:
OK, well at least he admits there are several papers with errors...
PACE is a case study in how to systematically maximise known methodological biases and confounders, and arbitrarily declare them to be legitimate therapeutic benefits.
Separate names with a comma.